These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 9316823

  • 21. Pharmacokinetics, tissue distribution, and stability of antisense oligodeoxynucleotide phosphorothioate ISIS 3466 in mice.
    Saijo Y, Perlaky L, Wang H, Busch H.
    Oncol Res; 1994; 6(6):243-9. PubMed ID: 7865900
    [Abstract] [Full Text] [Related]

  • 22. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS, Kirby L, Kumar D, Cullen EI, Pratt RD, Hahne WA.
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [Abstract] [Full Text] [Related]

  • 23. Correlation of toxicity and pharmacokinetic properties of a phosphorothioate oligonucleotide designed to inhibit ICAM-1.
    Henry SP, Templin MV, Gillett N, Rojko J, Levin AA.
    Toxicol Pathol; 1999 Nov; 27(1):95-100. PubMed ID: 10367680
    [Abstract] [Full Text] [Related]

  • 24. A nonradioisotope biomedical assay for intact oligonucleotide and its chain-shortened metabolites used for determination of exposure and elimination half-life of antisense drugs in tissue.
    Geary RS, Matson J, Levin AA.
    Anal Biochem; 1999 Oct 15; 274(2):241-8. PubMed ID: 10527522
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Bioavailability and therapeutic activity of alicaforsen (ISIS 2302) administered as a rectal retention enema to subjects with active ulcerative colitis.
    Miner PB, Geary RS, Matson J, Chuang E, Xia S, Baker BF, Wedel MK.
    Aliment Pharmacol Ther; 2006 May 15; 23(10):1427-34. PubMed ID: 16669957
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. In vivo distribution and metabolism of a phosphorothioate oligonucleotide within rat liver after intravenous administration.
    Graham MJ, Crooke ST, Monteith DK, Cooper SR, Lemonidis KM, Stecker KK, Martin MJ, Crooke RM.
    J Pharmacol Exp Ther; 1998 Jul 15; 286(1):447-58. PubMed ID: 9655890
    [Abstract] [Full Text] [Related]

  • 30. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides.
    Bennett CF, Chiang MY, Chan H, Shoemaker JE, Mirabelli CK.
    Mol Pharmacol; 1992 Jun 15; 41(6):1023-33. PubMed ID: 1352033
    [Abstract] [Full Text] [Related]

  • 31. Pharmacokinetics of an antisense oligonucleotide injected intravitreally in monkeys.
    Leeds JM, Henry SP, Bistner S, Scherrill S, Williams K, Levin AA.
    Drug Metab Dispos; 1998 Jul 15; 26(7):670-5. PubMed ID: 9660849
    [Abstract] [Full Text] [Related]

  • 32. Effects of an antisense oligonucleotide inhibitor of human ICAM-1 on fetal development in rabbits.
    Henry SP, Denny KH, Templin MV, Yu RZ, Levin AA.
    Birth Defects Res B Dev Reprod Toxicol; 2004 Dec 15; 71(6):368-73. PubMed ID: 15617022
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
    Ramael S, De Smedt F, Toublanc N, Otoul C, Boulanger P, Riethuisen JM, Stockis A.
    Clin Ther; 2006 May 15; 28(5):734-44. PubMed ID: 16861095
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Alicaforsen. Isis Pharmaceuticals.
    Gewirtz AT, Sitaraman S.
    Curr Opin Investig Drugs; 2001 Oct 15; 2(10):1401-6. PubMed ID: 11890355
    [Abstract] [Full Text] [Related]

  • 39. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
    O'Farrell AM, van Vliet A, Abou Farha K, Cherrington JM, Campbell DA, Li X, Hanway D, Li J, Guler HP.
    Clin Ther; 2007 Aug 15; 29(8):1692-705. PubMed ID: 17919550
    [Abstract] [Full Text] [Related]

  • 40. Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study.
    Ramael S, Daoust A, Otoul C, Toublanc N, Troenaru M, Lu ZS, Stockis A.
    Epilepsia; 2006 Jul 15; 47(7):1128-35. PubMed ID: 16886975
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.